Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Séverine André
Observed names:
Andre, Séverine,
André Séverine,
Séverine Andre
Institution:
University of Mons
Observed institution:
University of Mons
ORCID:
0000-0003-1797-3290
Observed ORCID:
0000-0003-1797-3290
OpenAlex ID:
A5040094209
Development of an LDL Receptor-Targeted Peptide Susceptible to Facilitate the Brain Access of Diagnostic or Therapeutic Agents
2020
·
Séverine André
, Lionel Larbanoix
, et al.
·
Biology
·
27
PDF
Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier
2017
·
Séverine André
, Emilie Ansciaux
, et al.
·
Journal of Alzheimer s Disease
·
17
PDF
Modulation of Cytosolic Phospholipase A2 as a Potential Therapeutic Strategy for Alzheimer’s Disease
2023
·
Séverine André
, Sébastien Verteneuil
, et al.
·
Journal of Alzheimer s Disease Reports
·
4
PDF
Peptide Targeting of Cytosolic Phospholipase A2 as a Novel Therapeutic Strategy in Alzheimer’s Disease
2026
·
Chartier, Honorine
, Andre, Séverine
, et al.
·
ORBi UMONS
PDF
Cytosolic Phospholipase A2 as a Promising Target for Innovative Therapeutic Approach in Alzheimer’s Disease
2026
·
Chartier, Honorine
, Andre, Séverine
, et al.
·
ORBi UMONS
Peptides Binding to Ldl-receptor as Carriers for Crossing the Blood Brain Barrier
2019
·
Burtea, Carmen
, Andre, Séverine
, et al.
·
ORBi UMONS
A promising phospholipase A2 targeted peptide slowing amyloid beta pathology in an Alzheimer's disease mouse model
2019
·
Andre, Séverine
, Atakana Lukulu, Jean Mazarin
, et al.
·
ORBi UMONS
PDF
Nouvelle Approche de Ciblage Moléculaire dans le Domaine de la Santé
2019
·
TCHEOUBI, Sègbédé Edgard Roméo
, Andre, Séverine
, et al.
·
ORBi UMONS
PDF
Development of an original phospholipase A2-targeted peptide able to reduce amyloid pathology in a mouse model of Alzheimer’s disease
2019
·
Séverine André
, Jean Atakana Lukulu
, et al.
·
Frontiers in Neuroscience
Phospholipase A2 targeting for the development of an original therapeutic strategy in the context of Alzheimer’s disease
2018
·
Séverine Andre
, Carmen BURTEA
Therapy of Alzheimer's disease: inhibitory potential of a phospholipase A2-targeted peptide able to cross the blood-brain barrier
2018
·
Andre, Séverine
, Lecomte, Marine
, et al.
·
ORBi UMONS
A novel therapeutic strategy for Alzheimer’s disease: utility of peptides targeting phospholipase A2 and able to cross the blood-brain barrier through the LDL receptor
2018
·
Séverine André
, Jean Atakana
, et al.
·
Frontiers in Neuroscience
Blood-brain barrier crossing for improving brain access using a peptide able to bind a receptor-mediated transcytosis
2017
·
Andre, Séverine
, Daldal, Fatima
, et al.
·
ORBi UMONS
Towards the therapy of Alzheimer's disease via the inhibition of a phospholipase A2 isoform using peptides able to cross the blood-brain barrier
2017
·
Andre, Séverine
, Daldal, Fatima
, et al.
·
ORBi UMONS
Targeting phospholipase A2 for the treatment of Alzheimer's disease through a peptidic modulation
2017
·
Andre, Séverine
, Daldal, Fatima
, et al.
·
ORBi UMONS
The phospholipase A2 signaling as a new therapeutic biomarker of Alzheimer’s disease: modulation through phage display-derived peptides able to cross the blood-brain barrier
2017
·
Séverine André
, Fatima Daldal
, et al.
·
Frontiers in Neuroscience
Phospholipase A2 modulation in Alzheimer’s disease: new approach of treatment using peptides able to accede to the brain through the LDL receptor
2016
·
Séverine André
, Fatima Daldal
, et al.
·
ORBi UMONS
Targeting amyloid plaques for the early diagnosis of Alzheimer's disease: validation of a vectorized superparamagnetic contrast agent able to cross the blood-brain barrier
2016
·
Andre, Séverine
, Ansciaux, Emilie
, et al.
·
ORBi UMONS
Stratégie thérapeutique de la maladie d'Alzheimer par délivrance ciblée et modulation peptidique d'une phospholipase
2016
·
Séverine André
, Sébastien Verteneuil
, et al.
·
ORBi UMONS
Approche thérapeutique de la maladie d'Alzheimer : passage de la barrière hémato-encéphalique et modulation peptidique d'une phospholipase A2
2016
·
Andre, Séverine
, Daldal, Fatima
, et al.
·
ORBi UMONS
Peptide-mediated modulation of a phospholipase isoform and blood-brain barrier transcytosis in the context of Alzheimer’s disease therapy
2016
·
Séverine André
, Sébastien Verteneuil
, et al.
·
ORBi UMONS
New therapeutic management of Alzheimer’s disease: interest to a phospholipase A2-targeted peptide able to cross the blood-brain barrier through the LDL receptor
2016
·
André Séverine
, Daldal Fatima
, et al.
·
Frontiers in Aging Neuroscience
Development of a new therapeutic approach for Alzheimer's disease by phospholipase pathway modulation and blood-brain barrier shuttling
2015
·
Andre, Séverine
, Verteneuil, Sébastien
, et al.
·
ORBi UMONS
The targeting of phospholipase signaling and of LDL receptor aiming to develop a new therapeutic approach for Alzheimer's disease management
2015
·
Andre, Séverine
, Verteneuil, Sébastien
, et al.
·
ORBi UMONS
Toward the development of a therapeutic strategy applied to Alzheimer's disease via phospholipase signaling
2015
·
Andre, Séverine
, Verteneuil, Sébastien
, et al.
·
ORBi UMONS
Show more works
View as search
Works count:
27
Citation count:
48
H-index:
3
I10-index:
2
Year
Topic
Type